Enhancing antigen presentation in cancer stem cells via peptide-based nanoparticles for effective immunotherapy
Authors:
- 5 July 2025
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 385, 114001
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32201156)
- National Natural Science Foundation of China (82273478)
- National Natural Science Foundation of China (U23A20459)
- National Natural Science Foundation of China (82173176)
- Natural Science Foundation of Henan Province (242300421016)
- Natural Science Foundation of Henan Province (242300421196)
- Natural Science Foundation of Henan Province (232301420010)
This publication has 43 references indexed in Scilit:
- A Pyroptosis‐Inducing Arsenic(III) Nanomicelle Platform for Synergistic Cancer ImmunotherapyAdvanced Healthcare Materials, 2024
- Biomimetic-gasdermin-protein-expressing nanoplatform mediates tumor-specific pyroptosis for cancer immunotherapyJournal of Controlled Release, 2024
- Adoptive cell therapy for cancer treatmentExploration, 2023
- Epigenetic reprogramming of carrier free photodynamic modulator to activate tumor immunotherapy by EZH2 inhibitionBiomaterials, 2022
- A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasisBiomaterials, 2022
- Selectively enhancing radiosensitivity of cancer cells via in situ enzyme-instructed peptide self-assemblyActa Pharmaceutica Sinica B, 2020
- An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in CancerCancer Cell, 2019
- Cancer Stem Cells: The Architects of the Tumor EcosystemCell Stem Cell, 2019
- Quiescent Tissue Stem Cells Evade Immune SurveillanceImmunity, 2018
- Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer ImmunotherapyAngewandte Chemie International Edition, 2015